AR064003A1 - Quinazolinas sustituidas - Google Patents

Quinazolinas sustituidas

Info

Publication number
AR064003A1
AR064003A1 ARP070105273A ARP070105273A AR064003A1 AR 064003 A1 AR064003 A1 AR 064003A1 AR P070105273 A ARP070105273 A AR P070105273A AR P070105273 A ARP070105273 A AR P070105273A AR 064003 A1 AR064003 A1 AR 064003A1
Authority
AR
Argentina
Prior art keywords
group
alkyl
hydrogen
groups
bromine
Prior art date
Application number
ARP070105273A
Other languages
English (en)
Spanish (es)
Inventor
Bernard Golding
Richard Franklin
Original Assignee
Shire Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Llc filed Critical Shire Llc
Publication of AR064003A1 publication Critical patent/AR064003A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP070105273A 2006-11-28 2007-11-28 Quinazolinas sustituidas AR064003A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0623749.9A GB0623749D0 (en) 2006-11-28 2006-11-28 Substituted quinazolines

Publications (1)

Publication Number Publication Date
AR064003A1 true AR064003A1 (es) 2009-03-04

Family

ID=37671459

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070105273A AR064003A1 (es) 2006-11-28 2007-11-28 Quinazolinas sustituidas

Country Status (15)

Country Link
EP (1) EP2097390A1 (fr)
JP (1) JP2010511031A (fr)
KR (1) KR20090089865A (fr)
CN (1) CN101558048B (fr)
AR (1) AR064003A1 (fr)
AU (1) AU2007327048B2 (fr)
BR (1) BRPI0719568A2 (fr)
CA (1) CA2670168A1 (fr)
EA (1) EA017139B1 (fr)
GB (1) GB0623749D0 (fr)
IL (1) IL198808A0 (fr)
MX (1) MX2009005578A (fr)
MY (1) MY149620A (fr)
TW (1) TW200829252A (fr)
WO (1) WO2008065445A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0822970D0 (en) * 2008-12-17 2009-01-21 Shire Llc Process for the preparation of anagrelide and analogues
GB201004495D0 (en) 2010-03-18 2010-05-05 Shire Llc Subtituted quinazolines
CN103254197A (zh) * 2013-05-29 2013-08-21 黑龙江大学 一种盐酸阿那格雷的制备方法
EP3236967B1 (fr) 2014-12-22 2019-10-16 SUDA Pharmaceuticals Ltd Prévention et traitement d'une maladie métastatique chez des patients atteints d'un cancer et souffrant de thrombocytose

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146718A (en) * 1978-04-10 1979-03-27 Bristol-Myers Company Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides
US6194420B1 (en) * 1999-11-30 2001-02-27 Roberts Laboratories Inc. 2-amino-5,6-dichloro-3,4-dihydroquinazoline, its method of making and using and pharmaceutical compositions thereof
DE10301105B4 (de) * 2003-01-09 2005-11-24 Chemisch-Pharmazeutisches Labor, Rolf Sachse Gmbh Verwendung von 2-Amino-2H-chinazolin-Derivaten zur Behandlung von myeloproliferativen Erkrankungen, Bluthochdruck und Bronchodilation
WO2004064841A1 (fr) * 2003-01-23 2004-08-05 Shire Holdings Ag Formulation et methodes de traitement de la thrombocythemie
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia

Also Published As

Publication number Publication date
MX2009005578A (es) 2009-07-29
CN101558048A (zh) 2009-10-14
EA200900742A1 (ru) 2010-08-30
AU2007327048B2 (en) 2012-01-12
TW200829252A (en) 2008-07-16
BRPI0719568A2 (pt) 2013-12-10
IL198808A0 (en) 2010-02-17
EA017139B1 (ru) 2012-10-30
JP2010511031A (ja) 2010-04-08
WO2008065445A1 (fr) 2008-06-05
CN101558048B (zh) 2012-07-25
EP2097390A1 (fr) 2009-09-09
CA2670168A1 (fr) 2008-06-05
AU2007327048A1 (en) 2008-06-05
MY149620A (en) 2013-09-13
GB0623749D0 (en) 2007-01-10
KR20090089865A (ko) 2009-08-24

Similar Documents

Publication Publication Date Title
CO6382182A2 (es) Proceso para la preparación de benzonorbornen-5-il-amidas del ácido pirazolil-4-carboxílico.
AR071385A1 (es) Compuestos de 2-imino-3-metil pirrolopirimidinona sustituida con tiofenilo,composiciones farmaceuticas que los contienen,y uso de los mismos para el tratamiento de patologias asociadas con la proteina beta amiloide,tales como alzheimer y otros formas de demencia.
AR059590A1 (es) Inhibidores de quinasa basados en la hidantoina
ES2722048T3 (es) Compuestos de triazolopirimidina y usos de los mismos
AR085960A1 (es) 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2
PE20200447A1 (es) Compuestos de biheteroarilo y usos de los mismos
AR066043A1 (es) Derivados de benzamida sustituida como inhibidores de la 11-beta-hidroxi esteroide deshidrogenasa tipo 1(11betahsd1)
PE20150230A1 (es) Nuevos diazaespirocicloalcanos y azaespirocicloalcanos
AR054560A1 (es) Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer
AR051995A1 (es) Derivados de tieno-piridina como intensificadores alostericos de gaba -b
PE20080552A1 (es) Derivados de alcoholes 1-fenil-2-piridinil alquilenicos como inhibidores de fosfodiesterasa
PE20121047A1 (es) Derivados de tiazolilpiperidina como fungicidas
AR079342A1 (es) Derivados de azol y metodos para producirlos, compuestos intermediarios para los derivados y metodos para producirlos, asi como tambien agentes agrohorticolas y agentes protectores de materiales industriales que contienen los derivados
AR062797A1 (es) Derivados de piperidina como inhibidores de renina, composiciones farmaceuticas.
CO6210770A2 (es) Compuestos 2-aril-5-heterociclil-ciclohexan-1, 3 diona y su uso como herbicidas
PE20130375A1 (es) Compuestos de triazolopiridinas y triazolopirazinas inhibidores de c-met y composiciones de los mismos
AR049647A1 (es) Cis-imidazolinas
AR062677A1 (es) Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden
AR083542A1 (es) Piperidin-4-il-azetidin diamidas como inhibidores de monoacilglicerol lipasa
UY30499A1 (es) Derivados de amina utiles como agentes anticancerigenos
PE20180030A1 (es) Compuestos biciclicos de sulfonamida cetona
CO2020001326A2 (es) Nuevos compuestos heterocíclicos como inhibidores de cdk8/19
AR054341A1 (es) Combinaciones sinergicas de compuestos activos fungicidas
AR070648A1 (es) Derivados de bencimidazol sustituido
PE20142282A1 (es) Nuevos derivados de aril-quinolina

Legal Events

Date Code Title Description
FB Suspension of granting procedure